Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
23.09
-0.50 (-2.12%)
At close: Sep 25, 2025, 4:00 PM EDT
23.17
+0.08 (0.35%)
Pre-market: Sep 26, 2025, 5:29 AM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.27 billion as of September 26, 2025. Its market cap has increased by 22.66% in one year.
Market Cap
2.27B
Enterprise Value
1.27B
1-Year Change
22.66%
Ranking
Category
Stock Price
$23.09
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.27B, an increase of 591.89%. That is a compound annual growth rate of 40.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2025 | 2.32B | 17.45% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.59B |
| Johnson & Johnson | 425.26B |
| AbbVie | 393.25B |
| UnitedHealth Group | 314.89B |
| Novo Nordisk | 262.84B |
| Novartis AG | 238.07B |
| Abbott Laboratories | 236.51B |
| AstraZeneca | 235.93B |